


Searching News Database: nucleic acid
HSMN NewsFeed - 20 Feb 2026
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
HSMN NewsFeed - 19 May 2025
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
HSMN NewsFeed - 27 Jun 2023
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
HSMN NewsFeed - 14 Oct 2022
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
HSMN NewsFeed - 3 Jun 2022
Caris Life Sciences Introduces the Caris Assure(TM) Liquid Biopsy Assay at ASCO 2022
Caris Life Sciences Introduces the Caris Assure(TM) Liquid Biopsy Assay at ASCO 2022
HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
HSMN NewsFeed - 22 Feb 2022
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
HSMN NewsFeed - 12 Oct 2021
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
HSMN NewsFeed - 30 Aug 2021
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
HSMN NewsFeed - 17 May 2021
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
HSMN NewsFeed - 11 Jun 2020
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
HSMN NewsFeed - 4 May 2020
Co-Diagnostics, Inc. Announces Government Approvals and Increased Orders for COVID-19 Test Kits
Co-Diagnostics, Inc. Announces Government Approvals and Increased Orders for COVID-19 Test Kits
HSMN NewsFeed - 6 Apr 2020
Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test
Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test
HSMN NewsFeed - 12 Aug 2019
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
HSMN NewsFeed - 2 May 2019
Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test
Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test
HSMN NewsFeed - 4 Jan 2019
LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical
LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical
HSMN NewsFeed - 6 Dec 2018
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
HSMN NewsFeed - 9 Nov 2018
FDA authorizes emergency use of first Ebola fingerstick test with portable reader
FDA authorizes emergency use of first Ebola fingerstick test with portable reader
HSMN NewsFeed - 31 Oct 2018
1DROP Raises $4.25 Million to Develop Next-Generation Portable Medical Diagnostics
1DROP Raises $4.25 Million to Develop Next-Generation Portable Medical Diagnostics
HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
HSMN NewsFeed - 21 Aug 2018
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
HSMN NewsFeed - 19 Jun 2018
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
HSMN NewsFeed - 25 Jan 2018
Aptima(R) HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval
Aptima(R) HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval
HSMN NewsFeed - 20 Jun 2017
Hologic Announces FDA Clearance of Aptima(R) Assay to Detect Herpes Simplex Virus 1 & 2
Hologic Announces FDA Clearance of Aptima(R) Assay to Detect Herpes Simplex Virus 1 & 2
HSMN NewsFeed - 20 Feb 2017
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
HSMN NewsFeed - 16 Feb 2017
FDA Grants PMA Approval for Hologic's Aptima(R) Hepatitis C Quant Dx Assay
FDA Grants PMA Approval for Hologic's Aptima(R) Hepatitis C Quant Dx Assay
HSMN NewsFeed - 6 Feb 2017
Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development
Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development
HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
HSMN NewsFeed - 16 Jan 2017
Bio-Rad to Acquire RainDance Technologies and Droplet Intellectual Property
Bio-Rad to Acquire RainDance Technologies and Droplet Intellectual Property
HSMN NewsFeed - 13 Dec 2016
Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
HSMN NewsFeed - 19 Jul 2016
TapImmune Appoints Dr. John N. Bonfiglio as President and Chief Operating Officer
TapImmune Appoints Dr. John N. Bonfiglio as President and Chief Operating Officer
HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
HSMN NewsFeed - 9 Nov 2015
Spring Bank Pharmaceuticals Names Nezam Afdhal, MD as Chief Medical Officer
Spring Bank Pharmaceuticals Names Nezam Afdhal, MD as Chief Medical Officer
HSMN NewsFeed - 16 Jul 2015
Alere Receives FDA CLIA Waiver for Alere(TM) i Strep A Rapid Molecular Test
Alere Receives FDA CLIA Waiver for Alere(TM) i Strep A Rapid Molecular Test
HSMN NewsFeed - 18 Jun 2015
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
HSMN NewsFeed - 23 Feb 2015
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
HSMN NewsFeed - 28 Jul 2014
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep
HSMN NewsFeed - 28 Jul 2014
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
HSMN NewsFeed - 28 Jul 2014
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
HSMN NewsFeed - 26 Mar 2014
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
HSMN NewsFeed - 30 Dec 2013
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
HSMN NewsFeed - 1 Oct 2013
First urine-based cancer mutation monitoring test available from Trovagene
First urine-based cancer mutation monitoring test available from Trovagene
HSMN NewsFeed - 22 Aug 2013
diaDexus, Inc. Appoints Ralf Schoenbrunner to Senior Vice President, Research and Early Development
diaDexus, Inc. Appoints Ralf Schoenbrunner to Senior Vice President, Research and Early Development
HSMN NewsFeed - 12 Aug 2013
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
HSMN NewsFeed - 27 Jun 2013
Cepheid Receives FDA Clearance For Updated Xpert MRSA/SA Blood Culture (BC) Test
Cepheid Receives FDA Clearance For Updated Xpert MRSA/SA Blood Culture (BC) Test
HSMN NewsFeed - 27 Mar 2013
AdvanDx, Inc. Elects Former Roche Molecular Systems CEO, Heiner Dreismann, Ph.D., to its Board of Directors
AdvanDx, Inc. Elects Former Roche Molecular Systems CEO, Heiner Dreismann, Ph.D., to its Board of Directors
HSMN NewsFeed - 25 Jan 2013
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
HSMN NewsFeed - 14 Jan 2013
Hologic Announces FDA Clearance of APTIMA Trichomonas for Use on PANTHER System
Hologic Announces FDA Clearance of APTIMA Trichomonas for Use on PANTHER System
HSMN NewsFeed - 4 Jan 2013
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
HSMN NewsFeed - 28 Nov 2012
Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
HSMN NewsFeed - 19 Nov 2012
Abacus Diagnostica Receives CE Mark for its Rapid Direct PCR Test for Toxigenic Clostridium Difficile
Abacus Diagnostica Receives CE Mark for its Rapid Direct PCR Test for Toxigenic Clostridium Difficile
HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
HSMN NewsFeed - 2 Apr 2012
Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
HSMN NewsFeed - 2 Apr 2012
MolecularMD Closes $6 Million Series B Financing and Announces Ensuing Growth Initiatives
MolecularMD Closes $6 Million Series B Financing and Announces Ensuing Growth Initiatives
HSMN NewsFeed - 28 Mar 2012
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
HSMN NewsFeed - 20 Dec 2011
Todd R. Nelson Ph.D. Named President & Chief Executive Officer of MP Biomedicals
Todd R. Nelson Ph.D. Named President & Chief Executive Officer of MP Biomedicals
HSMN NewsFeed - 31 Oct 2011
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
HSMN NewsFeed - 7 Sep 2011
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
HSMN NewsFeed - 29 Jun 2011
Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam
Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam
HSMN NewsFeed - 19 May 2011
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
HSMN NewsFeed - 20 Apr 2011
Cerus Appoints William "Obi" Greenman as President and Chief Executive Officer
Cerus Appoints William "Obi" Greenman as President and Chief Executive Officer
HSMN NewsFeed - 17 Jan 2011
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
HSMN NewsFeed - 13 Jan 2011
Nanosphere Receives FDA Clearance for Respiratory Virus Subtyping Test Panel
Nanosphere Receives FDA Clearance for Respiratory Virus Subtyping Test Panel
HSMN NewsFeed - 14 Dec 2010
FDA Grants Hemispherx Biopharma Extension in Its Pending NDA for Treatment of Chronic Fatigue Syndrome (CFS)
FDA Grants Hemispherx Biopharma Extension in Its Pending NDA for Treatment of Chronic Fatigue Syndrome (CFS)
HSMN NewsFeed - 29 Sep 2010
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
HSMN NewsFeed - 9 Mar 2010
Newly Published Data Shows Chronix Biomedical's Serum DNA Assays Can Detect Early-Stage Breast Cancer
Newly Published Data Shows Chronix Biomedical's Serum DNA Assays Can Detect Early-Stage Breast Cancer
HSMN NewsFeed - 17 Feb 2010
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
HSMN NewsFeed - 26 Jan 2010
Idera Pharmaceuticals Announces the Appointment of Malcolm MacCoss, Ph.D., to Its Board of Directors
Idera Pharmaceuticals Announces the Appointment of Malcolm MacCoss, Ph.D., to Its Board of Directors
HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
HSMN NewsFeed - 13 Oct 2009
Nanosphere Announces FDA 510(k) Clearance of the Verigene(R) SP and Respiratory Virus Nucleic Acid Test
Nanosphere Announces FDA 510(k) Clearance of the Verigene(R) SP and Respiratory Virus Nucleic Acid Test
HSMN NewsFeed - 3 Feb 2009
Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
HSMN NewsFeed - 26 Jan 2009
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
HSMN NewsFeed - 31 Dec 2008
FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
HSMN NewsFeed - 28 Nov 2008
Attorney Thomas Equels Elected to Hemispherx Biopharma Board of Directors
Attorney Thomas Equels Elected to Hemispherx Biopharma Board of Directors
HSMN NewsFeed - 26 Nov 2008
Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
HSMN NewsFeed - 10 Nov 2008
Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
HSMN NewsFeed - 29 Sep 2008
Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
HSMN NewsFeed - 21 Jul 2008
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
HSMN NewsFeed - 16 Jun 2008
3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
HSMN NewsFeed - 11 Jun 2008
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
HSMN NewsFeed - 3 Jun 2008
Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
HSMN NewsFeed - 2 Jun 2008
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination
HSMN NewsFeed - 30 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
HSMN NewsFeed - 28 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
HSMN NewsFeed - 7 May 2008
Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business
Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business
HSMN NewsFeed - 22 Apr 2008
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
HSMN NewsFeed - 7 Mar 2008
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
HSMN NewsFeed - 5 Mar 2008
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
HSMN NewsFeed - 28 Feb 2008
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
HSMN NewsFeed - 29 Jan 2008
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
HSMN NewsFeed - 27 Dec 2007
Sequenom Announces New York State Approval of a Noninvasive Prenatal Test
Sequenom Announces New York State Approval of a Noninvasive Prenatal Test
HSMN NewsFeed - 21 Jun 2007
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
HSMN NewsFeed - 11 Jun 2007
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
HSMN NewsFeed - 5 Jun 2007
Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life Sciences, Inc.
Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life Sciences, Inc.
HSMN NewsFeed - 3 Jun 2007
QIAGEN and Digene Announce Merger Creating Market and Technology Leader In Molecular Diagnostics
QIAGEN and Digene Announce Merger Creating Market and Technology Leader In Molecular Diagnostics
HSMN NewsFeed - 31 May 2007
AcroMetrix Receives 510(k) Clearance for VeriSure(R) Pro HBV Blood Screening Controls
AcroMetrix Receives 510(k) Clearance for VeriSure(R) Pro HBV Blood Screening Controls
HSMN NewsFeed - 29 May 2007
LabCorp(R) Licenses Gene Methylation Technology for Prostate Cancer from Veridex, LLC
LabCorp(R) Licenses Gene Methylation Technology for Prostate Cancer from Veridex, LLC
HSMN NewsFeed - 23 May 2007
AdvanDx and bioMerieux Partner to Provide Rapid Results for Bloodstream Infections
AdvanDx and bioMerieux Partner to Provide Rapid Results for Bloodstream Infections
HSMN NewsFeed - 30 Apr 2007
3M, Gen-Probe Form Collaboration to Develop Rapid Molecular Tests to Combat Healthcare-Associated Infections
3M, Gen-Probe Form Collaboration to Develop Rapid Molecular Tests to Combat Healthcare-Associated Infections
HSMN NewsFeed - 25 Apr 2007
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
HSMN NewsFeed - 20 Apr 2007
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
HSMN NewsFeed - 19 Apr 2007
Allos Therapeutics' PDX Granted Orphan Medicinal Product Designation by the European Commission
Allos Therapeutics' PDX Granted Orphan Medicinal Product Designation by the European Commission
HSMN NewsFeed - 18 Apr 2007
Cepheid's Xpert(TM) MRSA Test for Methicillin-Resistant Staphylococcus Aureus Receives FDA Clearance
Cepheid's Xpert(TM) MRSA Test for Methicillin-Resistant Staphylococcus Aureus Receives FDA Clearance
HSMN NewsFeed - 2 Mar 2007
FDA Approves Gen-Probe's TIGRIS(R) Instrument to Screen Donated Blood for West Nile Virus
FDA Approves Gen-Probe's TIGRIS(R) Instrument to Screen Donated Blood for West Nile Virus
HSMN NewsFeed - 22 Feb 2007
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer
HSMN NewsFeed - 20 Feb 2007
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
HSMN NewsFeed - 13 Feb 2007
Carl Hull to Join Gen-Probe as Executive Vice President and Chief Operating Officer
Carl Hull to Join Gen-Probe as Executive Vice President and Chief Operating Officer
HSMN NewsFeed - 7 Feb 2007
IRIS Submits 510(k) Application To FDA For Its N.A.D.I.A. Prostate Cancer Test
IRIS Submits 510(k) Application To FDA For Its N.A.D.I.A. Prostate Cancer Test
HSMN NewsFeed - 17 Jan 2007
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
HSMN NewsFeed - 17 Jan 2007
Cepheid and bioMerieux Enter Into Strategic Agreements to Develop and Market Sepsis and MRSA Products
Cepheid and bioMerieux Enter Into Strategic Agreements to Develop and Market Sepsis and MRSA Products
HSMN NewsFeed - 3 Jan 2007
Third Wave Submits 510(k) to FDA for InPlex(TM) Cystic Fibrosis Molecular Test
Third Wave Submits 510(k) to FDA for InPlex(TM) Cystic Fibrosis Molecular Test
HSMN NewsFeed - 27 Dec 2006
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
HSMN NewsFeed - 30 Nov 2006
U.S. Court of Appeals Allows Enzo Biochem Patent Infringement Suit to Proceed
U.S. Court of Appeals Allows Enzo Biochem Patent Infringement Suit to Proceed
HSMN NewsFeed - 26 Oct 2006
Arrowhead Subsidiary, Insert Therapeutics, Inc., Raises $10 Million in Private Equity Financing
Arrowhead Subsidiary, Insert Therapeutics, Inc., Raises $10 Million in Private Equity Financing
HSMN NewsFeed - 26 Oct 2006
Cepheid Extends European Product Line With Launch of Xpert(TM) MRSA Test for GeneXpert(R) System
Cepheid Extends European Product Line With Launch of Xpert(TM) MRSA Test for GeneXpert(R) System
HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
HSMN NewsFeed - 12 Oct 2006
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
HSMN NewsFeed - 5 Oct 2006
Gen-Probe Receives FDA Approval for APTIMA(R) HIV-1 RNA Qualitative Assay for Clinical Diagnostic Use
Gen-Probe Receives FDA Approval for APTIMA(R) HIV-1 RNA Qualitative Assay for Clinical Diagnostic Use
HSMN NewsFeed - 3 Oct 2006
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
HSMN NewsFeed - 28 Sep 2006
Celera Identifies FCAR Genetic Polymorphism Associated with Increased Risk for Myocardial Infarction
Celera Identifies FCAR Genetic Polymorphism Associated with Increased Risk for Myocardial Infarction
HSMN NewsFeed - 20 Sep 2006
Gen-Probe Responds to FDA Questions on TIGRIS(R) / West Nile Virus Regulatory Application
Gen-Probe Responds to FDA Questions on TIGRIS(R) / West Nile Virus Regulatory Application
HSMN NewsFeed - 31 May 2006
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
HSMN NewsFeed - 31 May 2006
Advanced Viral Research (ADVR) Names Abbott Veteran Angelo S. Botter to its Board of Directors
Advanced Viral Research (ADVR) Names Abbott Veteran Angelo S. Botter to its Board of Directors
Additional items found! 184
Members Archive contains
184 additional stories matching:
nucleic acid
(Password required)
nucleic acid
(Password required)
